Pnc Financial Services Group, Inc. Enlivex Therapeutics Ltd. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding ENLV
# of Institutions
32Shares Held
2.87MCall Options Held
79.1KPut Options Held
0-
Armistice Capital, LLC New York, NY1.41MShares$1.39 Million0.03% of portfolio
-
Citizens Financial Group Inc231KShares$226,7950.0% of portfolio
-
Morgan Stanley New York, NY174KShares$170,1520.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$154,1460.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il68.9KShares$67,5570.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $18M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...